In summary, these data demonstrate that circHSPA8 promotes EMT by acting as a competitive inhibitor of miR‐195‐5p to upregulate the expression of WNT3A in BC, suggesting that dysregulation of circRNA in BC might be a pathological factor and potential therapeutic target. The gene discussed is WNT3A; the disease is breast cancer.